I-STAND R21: Reducing Sedentary Time in Older Adults

May 30, 2018 updated by: Kaiser Permanente

Take Active Breaks From Sitting (TABS): Reducing Sedentary Time in Older Adults

The investigators are doing a study to learn how to support patients aged 60+ in taking more breaks from sitting and reducing total sitting time. The goal of the study is to find out if a sitting time reduction intervention reduces sitting time compared with a control group.

Study Overview

Status

Completed

Detailed Description

More than one-third of American adults over 60 have a body mass index > 30 kg/m2. These older adults have more sedentary time than any other group -- an average of 10-11 hours per day. Reducing the sedentary behavior of older adults with obesity, rather than only promoting more intensive physical activity, could provide a more feasible approach to health promotion.

This randomized control pilot trial will evaluate a 12-week intervention to decrease sitting time and increase standing time and light physical activity among sedentary older adults a body mass index > 30 kg/m2 as compared to control group. Baseline and 12-week measurements include anthropometric measures, blood draw by finger stick, cardiovascular health assessments, physical function tasks, and a survey. The intervention will consist of two in-person visits with a health coach followed by phone-based coaching.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Washington
      • Seattle, Washington, United States, 98101
        • Kaiser Permanente Washington Health Research Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 89 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Kaiser Permanente Washington enrollees
  • Men and women
  • Age 60 - 89
  • BMI 30 - 50 (calculated based on most recent height ever and most recent weight taken within previous 18 months)
  • Primary care within Integrated Group Practice
  • Continuously enrolled at Kaiser Permanente Washington for previous 12 months
  • No record of death
  • Not on the No Contact list
  • Speaks and writes English
  • Able to hold a conversation by phone (no hearing or other limitations)
  • Self-reported sitting time of 6 hours/day or more
  • Self-reported ability to stand with or without an assistive device
  • Self-reported ability to walk one block with or without an assistive device
  • Available for the study duration
  • Able to come to Kaiser Permanente Washington Health Research Institute's research clinic for measurement visits
  • Willing to wear study activity monitors

Exclusion Criteria:

  • Resides in long-term care, hospice care, or skilled nursing facility (previous 12 months)
  • Wheelchair bound
  • Diagnosis of dementia, serious mental health disorder, or substance use disorder (previous 24 months)
  • Use of an assistive device

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: I-STAND
Participants randomly assigned to the I-STAND intervention group will receive 2 in-person health coaching sessions and 4 biweekly phone-based health coaching sessions. They will receive a wristband that gives a mild vibration after 20 minutes of inactivity and will be encouraged to stand if possible after each inactivity alert. Participants may also choose to receive biweekly email reminders in the weeks between coaching calls. They will also receive a workbook with content around reducing sitting time.
Participants receive health coaching, a workbook, an inactivity alert wristband, and feedback charts based on objective measurement of sedentary time.
Active Comparator: Healthy Living
Participants randomly assigned to the Healthy Living enhanced usual care control group will receive 1 in-person health coaching session and 5 biweekly check-in letters by mail. They will receive a workbook with general healthy living topics that are not expected to impact sitting time. All content is taken from Kaiser Permanente Washington's website and is available to all members. Participants will select topics of interest and review them on their own with no further health coaching.
Participants receive enhanced usual care based on general healthy living topics that are available to all Kaiser Permanente Washington enrollees.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Hours of Sitting Time
Time Frame: 12 weeks
Average hours of sitting time over the last 7 days measured at baseline and 12 weeks later
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sit-to-stand Transitions
Time Frame: 12 weeks
Change in average daily number of activPAL-measured sit-to-stand transitions, from baseline to 12 weeks
12 weeks
Periods of Sitting for 30+ Minutes
Time Frame: 12 weeks
Change in average daily number of activPAL-measured periods of sitting for 30+ minutes without standing, from baseline to 12 weeks
12 weeks
Physical Function
Time Frame: 12 weeks
Change in Short Physical Performance Battery (SPPB) scale score, from baseline to 12 weeks. The range of scores is 0 to 12, higher values represent better physical function.
12 weeks
Blood Pressure (Systolic Blood Pressure)
Time Frame: 12 weeks
Change in average of second and third blood pressure reading (for systolic blood pressure), from baseline to 12 weeks
12 weeks
Fasting Glucose (mg/dL)
Time Frame: 12 weeks
Change in fasting glucose (mg/dL) from finger stick blood draw, from baseline to 12 weeks
12 weeks
Total Cholesterol (mg/dL)
Time Frame: 12 weeks
Change in total cholesterol (mg/dL) from finger stick blood draw, from baseline to 12 weeks
12 weeks
Depressive Symptoms
Time Frame: 12 weeks
Change in Patient Health Questionnaire (PHQ-8) scale score, from baseline to 12 weeks. The scale range is 0 to 24 with higher scores representing higher depressive symptoms. Scores of 10 or more are considered major depression.
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2016

Primary Completion (Actual)

February 1, 2017

Study Completion (Actual)

February 1, 2017

Study Registration Dates

First Submitted

February 24, 2016

First Submitted That Met QC Criteria

February 25, 2016

First Posted (Estimate)

February 26, 2016

Study Record Updates

Last Update Posted (Actual)

June 29, 2018

Last Update Submitted That Met QC Criteria

May 30, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 1R21AG043853 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on I-STAND

Subscribe